Manufacturing
Advocacy related to cardiovascular health and reduction of residual risk after statins; National Defense Authorization Act for Fiscal Year 2021 (S.4049/H.R.6395)
HCR - Health Issues
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office
KING & SPALDING LLP
1700 Pennsylvania Avenue NW, Suite 900, Washington, DC, 20006, US
ALLISON F KASSIR SCOTT DZIENGELSKI (Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst. (2013-2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012), Staff Asst. (2010-2011); Energy and Commerce Committee: Staff (2015-2017)) DAVID JOSEPH FARBER
Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst. (2013-2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012), Staff Asst. (2010-2011); Energy and Commerce Committee: Staff (2015-2017)